Clinical trial
A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart…
NCT00283218 · University of Aarhus, Other · Completed
Key facts
| NCT number | NCT00283218 |
|---|---|
| Title | A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, Biphasic Insulin Aspart 30, 50 and 70. |
| Official title | A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, Biphasic Insulin Aspart 30, 50 and 70. - A Randomised, Quadruple Cross-Over Trial |
| Lead sponsor | University of Aarhus, Other |
| Collaborators | Novo Nordisk A/S Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Type 1 Diabetes |
| Intervention type | Drug |
| Interventions | NovoRapid, NovoMix 30, Bifasisk Insulin Aspart 50, BIAsp70 |
| Enrollment | 24 |
| Start date | Jan 1, 2006 |
| Completion | Aug 1, 2006 |
| First posted | Jan 27, 2006 |
| Last update posted | Aug 8, 2006 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: